Skip to main content

FR
EN

Drupal

Main navigation EN

About Crossject
Our technology
Therapeutic areas

Main navigation 2 EN

Finances
News
- Our news
- Press releases
Careers
- Working at Crossject
Contact

Search

Enter the terms you wish to search for.

Home
Finances
Crossject reports audited financial results for 2023

Crossject reports audited financial results for 2023

Image

Date de parution

2024/04/25

PDF du document

Press release FY 2023 Full Financials 24042024 EN.pdf279.28 KB

FINANCES CONTACT

Natasha DRAPEAU

+41 76 823 7527

Last financial releases

Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe

2024/05/02

Crossject reports audited financial results for 2023

2024/04/25

Crossject advances in its U.S. Strategy and reports Financial Results for 2023

2024/04/02

Menu Pied de page

News
Legal information
Sitemap
Privacy Terms
Cookies

FOLLOW US